说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 腹泻型肠易激综合征
1)  Diarrhea-predominant irritable bowel syndrome
腹泻型肠易激综合征
1.
The physical difference is not only the key to determine the occurrence of diarrhea-predominant irritable bowel syndrome,but also to determine the varieties of physique type.
体质差异不但是决定腹泻型肠易激综合征发病与否的关键,也决定其各种质型。
2.
Objective To observe the curative effect of Jiawei Tongxie decoction in treating diarrhea-predominant irritable bowel syndrome.
目的观察加味痛泻要方治疗腹泻型肠易激综合征的疗效。
2)  Diarrhea irritable bowel syndrome
腹泻型肠易激综合征
1.
[Methods]To select patients of excerpt diarrhea irritable bowel syndrome and constipation irritable bowel syndrome and divide them into two group:one is called treatment group and other is called comparison group.
[方法]选择腹泻型肠易激综合征与便秘型肠易激综合征患者分别分成治疗组和对照组,治疗后进行疗效观察,各型组间进行统计学分析。
3)  diarrhea-predominate irritable bowel syndrome
腹泻型肠易激综合征
1.
Objective:To observe the curative effect of treatment determination from liver and spleen on diarrhea-predominate irritable bowel syndrome.
目的:观察从肝脾论治腹泻型肠易激综合征的临床疗效。
4)  Women Diarrhea-predominant irritable bowel syndrome
女性腹泻型肠易激综合征
5)  Irritable bowel syndrome with constipation
肠易激综合征便秘型
6)  IBS-C
便秘型肠易激综合征
1.
Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description,clinical symptom and quality of life.
目的探讨替加色罗联合微生态制剂按需给药治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效和可行性。
2.
Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C)treated with Zhishu decoction.
目的探讨《金匮》枳术汤加减治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效。
3.
Objective: To study the clinical effect on C-irrtable bowel syndrome (IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description, clinical symptom and quality of life.
目的在应用替加色罗(商品名:泽马可)联合微生态制剂(商品名:美常安)治疗便秘型肠易激综合征过程中,通过对按需给药与系统给药两种治疗方式在改善患者大便性状、临床症状及生活质量方面的治疗效果进行比较,评价按需给药方式的有效性,从而探讨按需给药治疗的可行性,为临床治疗方案的制定提供一定参考。
补充资料:腹泻低钾无胃酸综合征


腹泻低钾无胃酸综合征
watery diarrhea %26 hypokalemia %26 achlorhydria syndrome,WDHA

见“胰致腹泻瘤”。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条